Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 275.25 Million HKD | 22.11% |
| 2022 | 225.41 Million HKD | -34.85% |
| 2021 | 345.96 Million HKD | 58.03% |
| 2020 | 218.92 Million HKD | -27.63% |
| 2019 | 302.5 Million HKD | 30.9% |
| 2018 | 231.09 Million HKD | 38.13% |
| 2017 | 167.29 Million HKD | 22.76% |
| 2016 | 136.28 Million HKD | 29.92% |
| 2015 | 104.89 Million HKD | 39.35% |
| 2014 | 75.27 Million HKD | 37.12% |
| 2013 | 54.89 Million HKD | 40.78% |
| 2012 | 38.99 Million HKD | 17.45% |
| 2011 | 33.2 Million HKD | 24.9% |
| 2010 | 26.58 Million HKD | 130.15% |
| 2009 | 11.55 Million HKD | -47.08% |
| 2008 | 21.82 Million HKD | 98.39% |
| 2007 | 11 Million HKD | 192.35% |
| 2006 | 3.76 Million HKD | -75.8% |
| 2005 | 15.54 Million HKD | 104.45% |
| 2004 | 7.6 Million HKD | 137.72% |
| 2003 | -20.16 Million HKD | -435.66% |
| 2002 | -3.76 Million HKD | -287.82% |
| 2001 | 2 Million HKD | 105.82% |
| 2000 | 973.69 Thousand HKD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 157.44 Million HKD | 0.0% |
| 2023 Q2 | 169.81 Million HKD | 0.0% |
| 2023 FY | 275.25 Million HKD | 22.11% |
| 2023 Q4 | 105.44 Million HKD | 0.0% |
| 2022 FY | 225.41 Million HKD | -34.85% |
| 2022 Q2 | 139.23 Million HKD | 0.0% |
| 2022 Q4 | 86.18 Million HKD | 0.0% |
| 2021 Q2 | 162.18 Million HKD | 0.0% |
| 2021 FY | 345.96 Million HKD | 58.03% |
| 2021 Q4 | 183.78 Million HKD | 0.0% |
| 2020 Q2 | 49.18 Million HKD | 0.0% |
| 2020 Q4 | 169.73 Million HKD | 0.0% |
| 2020 FY | 218.92 Million HKD | -27.63% |
| 2019 FY | 302.5 Million HKD | 30.9% |
| 2019 Q4 | 172.92 Million HKD | 0.0% |
| 2019 Q2 | 129.57 Million HKD | 0.0% |
| 2018 Q2 | 98.91 Million HKD | 0.0% |
| 2018 FY | 231.09 Million HKD | 38.13% |
| 2018 Q4 | 132.17 Million HKD | 0.0% |
| 2017 FY | 167.29 Million HKD | 22.76% |
| 2017 Q4 | 90.17 Million HKD | 0.0% |
| 2017 Q2 | 77.12 Million HKD | 0.0% |
| 2016 Q2 | 61.98 Million HKD | 0.0% |
| 2016 FY | 136.28 Million HKD | 29.92% |
| 2016 Q4 | 74.29 Million HKD | 0.0% |
| 2015 Q2 | 51.64 Million HKD | 0.0% |
| 2015 Q4 | 53.25 Million HKD | 0.0% |
| 2015 FY | 104.89 Million HKD | 39.35% |
| 2014 Q4 | 44.68 Million HKD | 0.0% |
| 2014 Q2 | 30.58 Million HKD | 0.0% |
| 2014 FY | 75.27 Million HKD | 37.12% |
| 2013 FY | 54.89 Million HKD | 40.78% |
| 2013 Q4 | 28.02 Million HKD | 0.0% |
| 2013 Q2 | 26.87 Million HKD | 0.0% |
| 2012 FY | 38.99 Million HKD | 17.45% |
| 2012 Q4 | - HKD | 0.0% |
| 2012 Q2 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2011 Q4 | - HKD | 0.0% |
| 2011 FY | 33.2 Million HKD | 24.9% |
| 2010 FY | 26.58 Million HKD | 130.15% |
| 2010 Q2 | 6.81 Million HKD | 0.0% |
| 2009 Q2 | 2.89 Million HKD | 0.0% |
| 2009 FY | 11.55 Million HKD | -47.08% |
| 2008 FY | 21.82 Million HKD | 98.39% |
| 2007 FY | 11 Million HKD | 192.35% |
| 2006 FY | 3.76 Million HKD | -75.8% |
| 2005 FY | 15.54 Million HKD | 104.45% |
| 2004 FY | 7.6 Million HKD | 137.72% |
| 2003 FY | -20.16 Million HKD | -435.66% |
| 2002 FY | -3.76 Million HKD | -287.82% |
| 2001 FY | 2 Million HKD | 105.82% |
| 2000 FY | 973.69 Thousand HKD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -162.055% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | 85.359% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 268.924% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 1892.522% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 622.265% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -1548.459% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 1054.338% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 359.481% |
| SSY Group Limited | 1.31 Billion HKD | 79.125% |
| JBM (Healthcare) Limited | 130.46 Million HKD | -110.987% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | -3.106% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 92.858% |